Titan Spine expanded its commercial launch of the nanoLOCK surface technology throughout the nation.
Here are five highlights.
1. This full U.S. launch follows the company's alpha introduction of the technology in certain market areas.
2. So far, Titan Spine has sold nanoLOCK implants in 14 hospitals in eight states.
3. The company is currently undergoing contract processes with a few larger hospital systems.
4. In October 2016, CMS created a new technology category and code for the nanoLOCK technology.
5. The FDA cleared the technology in 2014.